project id: TCGA-BLCA; case submitter id: TCGA-4Z-AA89; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 9.2; age at index: 60; days to birth: -22271; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1951; age at diagnosis: 22271; ajcc clinical t: TX; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1029.0; icd 10 code: C67.0; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Trigone of bladder; synchronous malignancy: Not Reported; tissue or organ of origin: Trigone of bladder; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; is ffpe: false; composition: Not Reported; days to collection: 763; days to sample procurement: 0; initial weight: 340.0; portion submitter id: TCGA-4Z-AA89-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 17.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 73.0; percent tumor nuclei: 87.0;